R&D News | pharmaphorum

News

Trial shows Roche's new flu drug helps reduce symptoms in at...

Baloxavir marboxil, a flu drug seen by Roche as a successor to Tamiflu, significantly sped time to relief for patients highly vulnerable to serious complications.

News

Humira developer Winter among Nobel chemistry prize winners

A scientist who pioneered the technology used to discover the biggest selling drug in the world, AbbVie’s Humira, was among a trio who received this year’s Nobel Prize in Chemistry.

News

Recardio ceases UK drug trials, blaming Brexit

Medical research firm Recardio has ceased all of its drug trials in the UK over concerns about Brexit.

News

Alnylam rare disease drug may be delayed

Alnylam may have to put hold off plans for an early FDA approval for its gene-silencing drug givosiran – because recruitment to a rare disease trial is going better than expected.<

News

GSK TB vaccine shows promise, but more trials needed

GlaxoSmithKline’s experimental TB vaccine has shown that it could help prevent the disease, but further research is needed to identify patients with the strongest response.

News

Alexion prepares filings for new rare disease use for Soliri...

Alexion is preparing filings in major markets for its rare disease drug Soliris in a new indication after a positive readout in a rare neurological disease.

Trial shows Roche's new flu drug helps reduce symptoms in at...

Humira developer Winter among Nobel chemistry prize winners

Recardio ceases UK drug trials, blaming Brexit

Alnylam rare disease drug may be delayed

GSK TB vaccine shows promise, but more trials needed

Alexion prepares filings for new rare disease use for Soliri...

Bayer plans filings for cardiac amyloidosis imaging agent

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks